Overexpression of transforming growth factor (TGF)-β1 and TGF-β3 genes in lung of toxic-inhaled patients

Experimental Lung Research

Volumn 36, Issue 5, 2010, Pages 284-291

  Zarin, Aref Arzan ^a   Behmanesh, Mehrdad ^a   Tavallaei, Mahmoud ^b   Shohrati, Majid ^b   Ghanei, Mostafa ^b  

^a TARBIAT MODARES UNIVERSITY   (Iran)

^b BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Bronchiolitis obliterans (BO); Efferocytosis; Toxic inhalants; Transforming growth factor (TGF )

Indexed keywords

GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3;

ADULT; AIRWAY REMODELING; ARTICLE; BRONCHIOLITIS OBLITERANS; CHEMICAL INJURY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GAS POISONING; GENE OVEREXPRESSION; HOMEOSTASIS; HUMAN; HUMAN TISSUE; IRAN; LUNG BIOPSY; LUNG TOXICITY; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN SECRETION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL TIME; TOXIC INHALATION;

ADULT; APOPTOSIS; BIOPSY; BRONCHIOLITIS OBLITERANS; BRONCHOSCOPY; CASE-CONTROL STUDIES; CHEMICAL WARFARE AGENTS; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; INHALATION EXPOSURE; IRAN; LUNG; MALE; MIDDLE AGED; MUSTARD GAS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA3; UP-REGULATION; VITAL CAPACITY; WAR;

EID: 77952834060     PISSN: 01902148     EISSN: 15210499     Source Type: Journal    
DOI: 10.3109/01902140903578868     Document Type: Article

References (57)

1. Khateri S, Ghanei M, Keshavarz S, Soroush M, Haines D: Incidence of lung, eye, and skin lesions as late complications in 34,000 Iranians with wartime exposure to mustard agent. J Occup Environ Med. 2003;45:1136-1143.
2. Aghanouri R, Ghanei M, Aslani J, Keivani-Amine H, Rastegar F, Karkhane A: Fibrogenic cytokine levels in bronchoalveolar lavage aspirates 15 years after exposure to sulfur mustard. Am J Physiol Lung Cell Mol Physiol. 2004;287:L1160-L1164.
3. Ghanei M, Mokhtari M, Mohammad MM, Aslani J: Bronchiolitis obliterans following exposure to sulfur mustard: chest high resolution computed tomography. Eur J Radiol. 2004;52:164-169.
4. Ghanei M, Moqadam FA, Mohammad MM, Aslani J: Tracheobronchomalacia and air trapping following mustard gas exposure. Am J Respir Crit Care Med. 2006;173:304-309.
5. Ghanei M, Tazelaar HD, Chilosi M, Harandi AA, Peyman M, Akbari HM, Shamsaei H, Bahadori M, Aslani J, Mohammadi A: An international collaborative pathologic study of surgical lung biopsies from mustard gas-exposed patients. Respir Med. 2008;102:825-830.
6. Ghanei M, Eshraghi M, Peyman M, Alaeddini F, Jalali AR, Sajadi V: Pulmonary function test trend in adult bronchiolitis obliterans. Tanaffos. 2007;6:40-46.
7. Blobe GC, Schiemann WP, Lodish HF: Role of transforming growth factor beta in human disease. N Engl J Med. 2000;342:1350-1358.
8. Schiller M, Javelaud D, Mauviel A: TGF-beta-induced SMAD signaling and gene regulation: consequences for extracellular matrix remodeling and wound healing. J Dermatol Sci. 2004;35:83-92.
9. Letterio J, Roberts A: Regulation of immune responses by TGF-beta. Annu Rev Immunol. 1998;16:137-161.
10. Annes J, Munger J, Rifkin D: Making sense of latent TGFbeta activation. J Cell Sci. 2003;116:217-224.
11. Bujak M, Frangogiannis NG: The role of TGF-β signaling in myocardial infarction and cardiac remodeling. Cardiovasc Res. 2007;74:184-195.
12. Bergeron C, Tulic MK, Hamid Q: Tools used to measure airway remodelling in research. Eur Respir J. 2007;29:596-604.
13. Boxall C, Holgate ST, Davies DE: The contribution of transforming growth factor-β and epidermal growth factor signalling to airway remodelling in chronic asthma. Eur Respir J. 2005;27:208-229.
14. Branton MH, Kopp B: TGF-β and fibrosis. Microbes Infect. 1999;1:1349-1365.
15. Coker RK, Laurent GJ, Jeffery PK, Bois RMd, Black CM, McAnulty RJ: Localisation of transforming growth factor beta1 and beta3 mRNA transcripts in normal and fibrotic human lung. Thorax. 2001;56:549-556.
16. Flood-Page P, Menzies-Gow A, Kay A, Robinson D: Eosinophil's role remains uncertain as anti-interleukin-5 only partially depletes numbers in asthmatic airway. Am J Respir Crit Care Med. 2003;167:199-204.
17. Henson PM, Vandivier RW, Douglas IS: Cell death, remodeling, and repair in chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2006;3:713-717.
18. Vandivier RW, Henson PM, Douglas IS: Burying the dead, the impact of failed apoptotic cell removal (efferocytosis) on chronic inflammatory lung disease. Chest. 2006;129:1673-1682.
19. Demedts IK, Demoor T, Bracke KR, Joos GF, Brusselle GG: Role of apoptosis in the pathogenesis of COPD and pulmonary emphysema. Respir Res. 2006;7:53.
20. Hodge S, Hodge G, Scicchitano R, Reynolds P, Holmes M: Alveolar macrophages from subjects with chronic obstructive pulmonary disease are deficient in their ability to phagocytose apoptotic airway epithelial cells. Immunol Cell Biol. 2003;81:289-296.
21. Vandivier RW, Fadok VA, Hoffmann PR, Bratton DL, Penvari C, Brown KK, Brain JD, Accurso FJ, Henson PM: Elastase-mediated phosphatidylserine receptor cleavage impairs apoptotic cell clearance in cystic fibrosis and bronchiectasis. J Clin Invest. 2002;109:661-670.
22. Aubert JD, Dalal BI, Bai TR, Roberts CR, Hayashi S, Hogg JC: Transforming growth factor beta 1 gene expression in human airways. Thorax. 1994;49:225-232.
23. Coker R, Laurent G, Shahzeidi S, Hernandez-Rodriguez N, Pantelidis P, Bois Rd, Jeffery P, McAnulty R: Diverse cellular TGF-beta 1 and TGF-beta 3 gene expression in normal human and murine lung. Eur Respir J. 1996;9:2501-2507.
24. Charpin J, Valcke J, Kettaneh L, Epardeau B, Stern M, Israel-Biet D: Peaks of transforming growth factor-beta mRNA in alveolar cells of lung transplant recipients as an early marker of chronic rejection. Transplantation. 1998;65:752-755.
25. Aris R, Walsh S, Chalermskulrat W, Hathwar V, Neuringer I: Growth factor upregulation during obliterative bronchiolitis in the mouse model. Am J Respir Crit Care Med. 2002;166:417-422.
26. Ramirez AM, Takagawa S, Sekosan M, Jaffe HA, Varga J, Roman J: Smad3 deficiency ameliorates experimental obliterative bronchiolitis in a heterotopic tracheal transplantation model. Am J Pathol. 2004;165:1223-1232.
27. El-Gamel A, Sim E, Hasleton P, Hutchinson J, Yonan N, Egan J, Campbell C, Rahman A, Sheldon S, Deiraniya A, Hutchinson IV: Transforming growth factor beta (TGF-beta) and obliterative bronchiolitis following pulmonary transplantation. J Heart Lung Transplant. 1999;18:828-837.
28. Bergmann M, Tiroke A, Schfer H, Barth J, Haverich A: Gene expression of profibrotic mediators in bronchiolitis obliterans syndrome after lung transplantation. Scand Cardiovasc J. 1998;32:97-103.
29. Derynck R, Zhang YE: Smad-dependent and Smad-independent pathways in TGF-b family signaling. Nature. 2003;425:577-584.
30. Lutz M, Knaus P: Integration of the TGF-beta pathway into the cellular signaling network. Cell Signal. 2002;14:977-988.
31. Mulder KM: Role of Ras and Mapks in TGFβ signaling. Cytokine Growth Factor Rev. 2000;11:23-35.
32. Yue J, Sun B, Liu G, Mulder KM: Requirement of TGF-βreceptor dependent activation of c-Jun N-terminal kinases (JNKs)/stress-activated protein kinases (Sapks) for TGF-β upregulation of the urokinase-type plasminogen activator receptor. J Cell Physiol. 2004;199:284-292.
33. Lee CG, Kang H-R, Homer RJ, Chupp G, Elias JA: Transgenic modeling of transforming growth factor-beta1, role of apoptosis in fibrosis and alveolar remodeling. Proc Am Thorac Soc. 2006;3:418-423.
34. Fargeas C, Wu C, Nakajima T, Cox D, Nutman T, Delespesse G: Differential effect of transforming growth factor beta on the synthesis of Th1- and Th2-like lymphokines by human T lymphocytes. Eur J Immunol. 1992;22:2173-2176.
35. Zhang X, Giangreco L, Broome L, Dargan C, Swain S: Control of CD4 effector fate: transforming growth factor beta 1 and interleukin 2 synergize to prevent apoptosis and promote effector expansion. J Exp Med. 1995;182:699-709.
36. Henson PM, Bratton DL, Fadok VA: Apoptotic cell removal. Curr Biol. 2001;11:R795-R805.
37. Ling E, Robinson D: Transforming growth factor-beta1: its antiinflammatory and pro-fibrotic effects. Clin Exp Allergy. 2002;32:175-178.
38. Martin M, Lefaix J, Delanian S: TGF-beta1 and radiation fibrosis: a master switch and a specific therapeutic target. Int J Radiat Oncol Biol Phys. 2000;47:277-290.
39. Nakao A, Fujii M, Matsumura R, Kumano K, Saito Y, Miyazono K, Iwamoto I. Transient gene transfer and expression of Smad7 prevents bleomycin-induced lung fibrosis in mice. J Clin Invest 1999;104:5-11.
40. Ashcroft GS, Yang X, Glick AB, Weinstein M, Letterio JJ, Mizel DE, Anzano M, Greenwell-Wild T, Wahl SM, Deng C, Roberts AB: Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response. Nat Cell Biol. 1999;1:260-266.
41. Flanders KC, Sullivan CD, Fujii M, Sowers A, Anzano MA, Arabshahi A, Major C, Deng C, Russo A, Mitchell JB, Roberts AB: Mice lacking Smad3 are protected against cutaneous injury induced by ionizing radiation. Am J Pathol. 2002;160:1057-1068.
42. Pittet J-F, Griffiths MJD, Geiser T, Kaminski N, Dalton SL, Huang X, Brown LAS, Gotwals PJ, Koteliansky VE, Matthay MA, Sheppard D: TGF-β is a critical mediator of acute lung injury. J Clin Invest. 2001;107:1537-1544.
43. Roberts A, Piek E, Böttinger E, Ashcroft G, Mitchell J, Flanders K: Is Smad3 a major player in signal transduction pathways leading to fibrogenesis? Chest. 2001;120:43-47.
44. Massague J: Wounding Smad. Nat Cell Biol. 1999;1:117-119.
45. Chenf MM, Lam A, Abraham JA, Schreiner GF, Joly AH: CTGF expression is induced by TGF-β in cardiac fibroblasts and cardiac myocytes: a potential role in heart fibrosis. J Mol Cell Cardiol. 2000;32:1805-1819.
46. Ihn H: Pathogenesis of fibrosis: role of TGF-beta and CTGF. Curr Opin Rheumatol. 2002;14:681-685.
47. Ponticos M, Holmes AM, Shi-wen X, Leoni P, Khan K, Rajkumar VS, Hoyles RK, Bou-Gharios G, Black CM, Denton CP, Abraham DJ, Leask A, Lindahl GE: Pivotal role of connective tissue growth factor in lung fibrosis: MAPK-dependent transcriptional activation of type I collagen. Arthritis Rheum. 2009;60:2142-2155.
48. Ryu JH, Myers JL, Swensen SJ: Bronchiolar disorders. Am J Respir Crit Care Med. 2003;168:1277-1292.
49. Hodge SJ, Hodge GL, Reynolds PN, Scicchitano R, Holmes M: Increased production of TGF-beta and apoptosis of T lymphocytes isolated from peripheral blood in COPD. Am J Physiol Lung Cell Mol Physiol. 2003;285:492-499.
50. DeCathelineau AM, Henson P: The final step in programmed cell death: phagocytes carry apoptotic cells to the grave. Essays Biochem. 2003;39:105-117.
51. Gardai S, McPhillips K, Frasch S, Janssen W, Starefeldt A, Murphy-Ullrich J, Bratton D, Oldenborg P, Michalak M, Henson P: Cell-surface calreticulin initiates clearance of viable or apoptotic cells through trans-activation of LRP on the phagocyte. Cell. 2005;123:321-334.
52. Serhan C, Savill J: Resolution of inflammation: the beginning programs the end. Nat Immunol. 2005;12:1191-1197.
53. Ogasawara J, Watanabe-Fukunaga R, Adachi M, Matsuzawa A, Kasugai T, Kitamura Y, Itoh N, Suda T, Nagata S: Lethal effect of the anti-Fas antibody in mice. Nature. 1993;364:806-809.
54. Fadok V, Bratton D, Konowal A, Freed P, Westcott J, Henson P: Macrophages that have digested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-b, PGE2 and PAF. J Clin Invest. 1998;90:1513-1522.
55. McDonald P, Fadok V, Bratton D, Henson P: Transcriptional and translational regulation of inflammatory mediator production by endogenous TGF-β in macrophages that have ingested apoptotic cells. J Immunol. 1999;163:6164-6172.
56. Fadok VA, Bratton DL, Henson PM: Phagocyte receptors for apoptotic cells: recognition, uptake, and consequences. J Clin Invest. 2001;108:957-962.
57. Freire-de-Lima CG, Xiao YQ, Gardai SJ, Bratton DL, Schiemann WP, Henson PM: Apoptotic cells, through transforming growth factor-beta, coordinately induce anti-inflammatory and suppress pro-inflammatory eicosanoid and NO synthesis in murine macrophages. J Biol Chem. 2006;281:38376-38384.